Q1FY26 Earnings: Real Estate & FMCG Win Big
DLF nearly doubled revenue while Aurobindo's profits fell 10.2%. Here's what the earnings divergence means for your portfolio.
sector · 4 August 2026 · 4 min read
Q1FY26 Earnings Show a Market That's Picking Winners Hard
Q1FY26 earnings season isn't telling one story. It's telling four or five simultaneously, and some of them contradict each other. [DLF](/stock/DLF) nearly doubled its consolidated revenue to ₹2,717 crore year-on-year, [ITC](/stock/ITC) posted a 19.6% revenue surge, and Hero MotoCorp's PAT jumped 65.2% on a *declining* 4.7% revenue base. Meanwhile, [Aurobindo Pharma](/stock/AUROPHARMA) watched its net profit drop 10.2% to ₹824 crore despite a modest 4% revenue uptick. If you're trying to read this as a broad market rally, you're going to get it wrong.
The central theme here isn't sector rotation in the traditional sense. It's margin architecture. Companies that managed cost structures tightly, or benefited from pricing power, delivered. Those exposed to input cost volatility or competitive pricing pressure got squeezed regardless of topline movement. That gap is widening, and investors who still buy sectors as monoliths are going to find themselves holding the wrong half.
DLF and ITC: What's Actually Driving the Numbers
[DLF](/stock/DLF) (NSE: DLF) doubling revenue isn't just a real estate cyclical story. It reflects a specific product mix shift: premium and luxury housing, particularly in Gurugram and Delhi NCR, has seen sustained demand from high-net-worth buyers who are largely insulated from interest rate sensitivity. DLF's new sales bookings have been tracking above ₹4,000 crore per quarter in recent periods, which means the revenue recognition now flowing through is the result of bookings made 12 to 18 months ago. The pipeline isn't empty. Stocks with FairStock Scores above 70 in the real estate segment have generally rewarded patience over the last 18 months, and DLF has been one of the cleaner stories in that cohort.
[ITC](/stock/ITC) (NSE: ITC) at 19.6% revenue growth deserves more credit than it typically gets from investors still anchored to its cigarette business narrative. The hotels segment ...
AI-generated market intelligence. Not investment advice.